SCHEMBL6581525

SCHEMBL6581525

CCCOc1c(N)ccc(OC)c1COc1ccc2nc(C)ccc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 5/20 0.39
ALDH1A1 P00352 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PDE10A Q9Y233 7/20 0.38
PPARG P37231 1/20 0.38
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
CASP6 P55212 1/20 0.36
TLR8 Q9NR97 1/20 0.36
GPBAR1 Q8TDU6 1/20 0.35
CYSLTR1 Q9Y271 1/20 0.35
TUBB4A P04350 1/20 0.35
TUBB P07437 1/20 0.35
TUBA3C P0DPH7 1/20 0.35
TUBA1B P68363 1/20 0.35
TUBA4A P68366 1/20 0.35
TUBB4B P68371 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6580627 0.90 NCF1 (0.41) NCF1ALDH1A1CASP1CASP7HSD17B10
SCHEMBL6580761 0.83 MAPT (0.42) ALDH1A1PDE10APPARGLMNA
SCHEMBL6580770 0.83 NCF1 (0.40) NCF1ALDH1A1CASP1CASP7HSD17B10
SCHEMBL6578833 0.83 NCF1 (0.40) NCF1ALDH1A1CASP1CASP7HSD17B10
SCHEMBL6578390 0.80 NQO1 (0.41) NCF1ALDH1A1CASP1CASP7HSD17B10
SCHEMBL6578780 0.78 NCF1 (0.40) NCF1ALDH1A1CASP1CASP7HSD17B10
SCHEMBL6581519 0.78 MCHR1 (0.50) ALDH1A1KDM4ELMNAPOLB
SCHEMBL6578484 0.78 NCF1 (0.39) NCF1ALDH1A1CASP1CASP7HSD17B10
SCHEMBL6578371 0.75 ALDH1A1 (0.44) ALDH1A1PDE10ALMNAPOLBTUBB4A
SCHEMBL6581464 0.74 KDM4E (0.44) NCF1ALDH1A1CASP1CASP7HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0867432-B1 Fused N-heterocyclic compounds substituted with benzyloxy, process for their preparation and their use as bradykinin receptor antagonists AVENTIS PHARMA GMBH (DE) 2004-06-09 EP disclosed
EP-0867432-A2 Fused N-heterocyclic compounds substituted with benzyloxy, process for their preparation and their use as bradykinin receptor antagonists HOECHST AKTIENGESELLSCHAFT (DE) 1998-09-30 EP disclosed